Federal contract award
75A50122C00031
ADVANCED RESEARCH AND DEVELOPMENT AND DELIVERY OF ADULT AND PEDIATRIC MIDAZOLAM AUTOINJECTORS THAT HAVE RECEIVED EMERGENCY USE AUTHORIZATION (EUA) OR FDA APPROVAL FOR THE TREATMENT OF STATUS EPILEPTICUS SEIZURES IN ADULT AND PEDIATRIC POPULATIONS (2+
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Department of Health and Human Services |
| Office | BARDA - ASPR / DAAPPO / BARDA DCMA |
| NAICS | 541714 — Research and Development in Biotechnology (except Nanobiotechnology) |
| PSC | AN13 — HEALTH R&D SERVICES; HEALTH CARE SERVICES; EXPERIMENTAL DEVELOPMENT |
| Parent award / vehicle | Not reported |
| Set-aside | NO SET ASIDE USED. |
| Pricing type | COST PLUS FIXED FEE |
| Obligations | $104.2M |
| Current contract value | $104.2M |
| Potential contract value / ceiling | $166.2M |
| Start date | Jun 22, 2022 |
| Current end date | Jun 21, 2027 |
| Potential end date | Jun 21, 2030 |
| Latest award activity | Sep 16, 2025 |
| Source loaded | Sep 26, 2026 |
Funding and modification history
Showing the latest 4 of 4 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| Sep 16, 2025 | P00003 | $11.3M | SUPPLEMENTAL FUNDING FOR CLIN 001 AND REVISED THE STATEMENT OF WORK. |
| May 31, 2024 | P00002 | $0 | ADVANCED RESEARCH AND DEVELOPMENT AND DELIVERY OF ADULT AND PEDIATRIC MIDAZOLAM AUTOINJECTORS THAT HAVE RECEIVED EMERGENCY USE AUTHORIZATION (EUA) OR FDA APPROVAL FOR THE TREATMENT OF STATUS EPILEPTICUS SEIZURES IN ADULT AND PEDIATRIC POPULATIONS (2+ |
| Sep 12, 2022 | P00001 | $0 | ADVANCED RESEARCH AND DEVELOPMENT AND DELIVERY OF ADULT AND PEDIATRIC MIDAZOLAM AUTOINJECTORS THAT HAVE RECEIVED EMERGENCY USE AUTHORIZATION (EUA) OR FDA APPROVAL FOR THE TREATMENT OF STATUS EPILEPTICUS SEIZURES IN ADULT AND PEDIATRIC POPULATIONS (2+ |
| Jun 9, 2022 | 0 | $92.9M | ADVANCED RESEARCH AND DEVELOPMENT AND DELIVERY OF ADULT AND PEDIATRIC MIDAZOLAM AUTOINJECTORS THAT HAVE RECEIVED EMERGENCY USE AUTHORIZATION (EUA) OR FDA APPROVAL FOR THE TREATMENT OF STATUS EPILEPTICUS SEIZURES IN ADULT AND PEDIATRIC POPULATIONS (2+ |
Estimated positioning window
Jun 21, 2029 – Dec 21, 2029
45/100
Why this recompete signal
Contract timing and recorded acquisition signals at the time of calculation.
Stored score: 45/100. Available recorded signals: 40 points.
- Contract end 2030-06-21 (1335 days from calculation)
- +5 points
- 121 historical awards in this buyer and category group
- +15 points
- 4 recorded award transactions
- +10 points
- Latest award action: 2025-09-16
- +0 points
- Parent award identifier recorded
- +0 points
- Solicitation identifier recorded
- +10 points
- Linked official forecast
- +0 points
- Calculated on
- 2026-10-25 10:18:04.631876+00:00
The historical group combines buyer, NAICS, and PSC. Multiple awards in this group do not by themselves establish repeated competitions.
Rule-based research score; it does not measure your chance of winning.
This older calculation does not retain a complete reproducible breakdown. Missing or changed inputs are not assigned invented points: Original award-value bonus input.
Recompete score calculated Oct 25, 2026.
Buyer contacts from matching notices
Matched on exact award/solicitation identifier and awarding agency. Source dates describe the notice, not current contact verification.
| Contact | Role | Published contact methods | Evidence | Source date |
|---|---|---|---|---|
| Jill Johnson, Contracting Officer | Contact | jill.johnson@hhs.gov 202-816-1148 | Source | Jul 15, 2021 |
| Kevin Restrepo, Contract Specialist | Contact | kevin.restrepo@hhs.gov 202-815-2367 | Source | Jul 15, 2021 |
| Jill Johnson, Contracting Officer | Contact | jill.johnson@hhs.gov 202-816-1148 | Source | Jul 2, 2021 |
| Kevin Restrepo, Contract Specialist | Contact | kevin.restrepo@hhs.gov 202-815-2367 | Source | Jul 2, 2021 |
| Jill Johnson, Contracting Officer | Contact | jill.johnson@hhs.gov 202-816-1148 | Source | Jun 17, 2021 |
| Kevin Restrepo, Contract Specialist | Contact | kevin.restrepo@hhs.gov 202-815-2367 | Source | Jun 17, 2021 |
| Jessica Coleman, Contract Specialist | Contact | Jessica.Coleman@hhs.gov 2027308664 | Source | Oct 22, 2020 |
| Jill Johnson, Contracting Officer | Contact | jill.johnson@hhs.gov 202-690-7137 | Source | Oct 22, 2020 |
Research next steps
- Check the linked forecast or SAM for a confirmed solicitation and current timing.
- Verify whether remaining options may extend performance beyond the current end date.
- Check the stated set-aside against the solicitation and current certifications.
- Review the award scope and buyer evidence before making a bid/no-bid decision.